Literature DB >> 14514740

Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Mark Mitsnefes1, Ping-Leung Ho, Paul T McEnery.   

Abstract

Hypertension frequently complicates the course of chronic renal insufficiency (CRI) in children. This study sought to define the role of hypertension in progression of CRI in children by using the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) CRI database. The study cohort consisted of 3834 patients aged 2 to 17 yr with an estimated GFR (eGFR) </=75 ml/min.1.73 m2 enrolled onto NAPRTCS. The time to end point was defined as the time between registry enrollment and progression to renal substitution therapy or a 10 ml/min.1.73 m2 drop in GFR from baseline, whichever was first. Forty-eight percent of the study patients had hypertension at baseline. There was a significant difference in reaching end points between hypertensive and normotensive children (58% versus 49%, respectively, P < 0.001). Significant difference in outcome between hypertensive and nonhypertensive patients was seen in children with eGFR 50 to 75 ml/min.1.73 m2 (P < 0.001). Multivariate Cox regression modeling demonstrated that systolic hypertension was a significant independent predictor of progression of CRI (P = 0.003). Other significant predictors of CRI progression in this model included older age (P = 0.0001), African American ethnicity (P = 0.03), acquired cause of renal disease (P = 0.0001), and baseline eGFR <50 ml/min.1.73 m2 (P = 0.0001). Hypertension is a highly significant and independent predictor for progression of CRI in children.

Entities:  

Mesh:

Year:  2003        PMID: 14514740     DOI: 10.1097/01.asn.0000089565.04535.4b

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  57 in total

1.  The effect of a multidisciplinary care clinic on the outcomes in pediatric chronic kidney disease.

Authors:  Salma Ajarmeh; Lee Er; Genevieve Brin; Ognjenka Djurdjev; Janis M Dionne
Journal:  Pediatr Nephrol       Date:  2012-06-05       Impact factor: 3.714

2.  The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease.

Authors:  Susan L Furth; Stephen R Cole; Jeffrey J Fadrowski; Arlene Gerson; Christopher B Pierce; Manju Chandra; Robert Weiss; Frederick Kaskel
Journal:  Pediatr Nephrol       Date:  2006-11-21       Impact factor: 3.714

Review 3.  Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations.

Authors:  Peter N Van Buren; Jula K Inrig
Journal:  Pediatr Nephrol       Date:  2011-02-01       Impact factor: 3.714

4.  Sleep and fatigue symptoms in children and adolescents with CKD: a cross-sectional analysis from the chronic kidney disease in children (CKiD) study.

Authors:  Maria-Eleni Roumelioti; Alicia Wentz; Michael F Schneider; Arlene C Gerson; Stephen Hooper; Mark Benfield; Bradley A Warady; Susan L Furth; Mark L Unruh
Journal:  Am J Kidney Dis       Date:  2010-01-19       Impact factor: 8.860

5.  A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program.

Authors:  Debora C Cerqueira; Cristina M Soares; Vanessa R Silva; Juliana O Magalhães; Isabella P Barcelos; Mariana G Duarte; Sergio V Pinheiro; Enrico A Colosimo; Ana Cristina Simões e Silva; Eduardo A Oliveira
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

Review 6.  Cardiovascular complications in pediatric end-stage renal disease.

Authors:  Rulan S Parekh; Samuel S Gidding
Journal:  Pediatr Nephrol       Date:  2004-12-15       Impact factor: 3.714

Review 7.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

8.  Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease.

Authors:  Amy C Wilson; Michael F Schneider; Christopher Cox; Larry A Greenbaum; Jeffrey Saland; Colin T White; Susan Furth; Bradley A Warady; Mark M Mitsnefes
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

Review 9.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

Review 10.  Treatment of hypertension in children and adolescents.

Authors:  Marc B Lande; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2007-08-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.